- Worldwide sales were $107.0 million, a 11.5% increase from the second quarter of 2012
- Net income was $7.4 million or $0.08 per diluted share; Non-GAAP diluted EPS was $0.21
- Non-GAAP Adjusted EBITDA was 34.0% of sales
Trade-Ideas LLC identified Globus Medical (GMED) as a "dead cat bounce" (down big yesterday but up big today) candidate
Here are Wednesday's top research calls, including upgrades for Coach and Alaska Air, and downgrades for Southwest Airlines and Twitter.
The health care sector is booming, but many stocks are overvalued. We pinpoint the best buys now in the medical device niche.